SHIONOGO & CO has a total of 20 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1962. It filed its patents most often in Russian Federation, Hungary and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are YAMANOUCHI PHARMACEUTICAL CO LTD, HAESSLE AB and EJSAJ AR END DI MENEDZHMENT KO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Russian Federation | 9 | |
#2 | Hungary | 5 | |
#3 | United States | 2 | |
#4 | Germany | 1 | |
#5 | United Kingdom | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Sweden | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Biotechnology | |
#5 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Nagata Wataru | 3 |
#2 | Tomita Kendzi | 2 |
#3 | Miyagava Masaesi | 2 |
#4 | Okano Azusa | 2 |
#5 | Kodzima Ejiti | 2 |
#6 | Inagaki Masanao | 2 |
#7 | Akiyama Tosiyuki | 2 |
#8 | Morimoto Kendzi | 2 |
#9 | Tamura Josinori | 2 |
#10 | Omura Sokhei | 2 |
Publication | Filing date | Title |
---|---|---|
RU2700703C2 | Heterocyclic derivative having activating ampk activity | |
US6420367B1 | Pyrimidine derivatives exhibiting antitumor activity | |
DE1212078B | Process for the preparation of 16, 17-epithioandrostanes |